查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1614185

栓塞預防設備市場：按設備類型、應用程式和最終用戶分類 - 2025-2030 年全球預測

Embolic Protection Devices Market by Device Type (Distal Filters, Distal Occlusion Devices, Proximal Occlusion Devices), Application (Cardiovascular Procedures, Neurovascular Procedures), End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年，栓塞防護設備市場價值為17.2億美元，預計到2024年將達到18.6億美元，複合年成長率為8.11%，到2030年將達到29.8億美元。

栓塞防護裝置（EPD）是一種介入裝置，旨在捕捉和清除經經皮冠狀動脈介入治療（PCI）和經導管主動脈瓣置換術（TAVR）等手術過程中脫落的碎片，在心血管手術中發揮著重要作用。這種需求源自於預防栓塞的需要，栓塞是一種可能導致中風和心肌梗塞的嚴重併發症。這些設備適用於各種手術，主要是心血管系統，最終用途市場擴展到醫院、心臟中心和門診手術中心。 EPD市場的成長受到心血管疾病盛行率的增加和對微創手術技術日益偏好的影響。此外，設備設計的技術進步，例如病患安全性和手術療效的提高，正在進一步推動市場。一個顯著的機會在於新興市場，這些市場的醫療基礎設施十分開拓，熟練專業人員的數量不斷增加，患者對心血管健康的認知不斷提高。然而，市場面臨著高成本、監管障礙以及需要熟練人員有效操作這些先進技術等限制。挑戰包括激烈的競爭和阻礙市場滲透的報銷問題。開發工作應專注於整合人工智慧和機器學習，以改善設備功能和患者治療效果，以及創建可重複使用、經濟高效的設備並提高可訪問性。您還可以透過探索與研究機構的夥伴關係和合作來培養創新解決方案。 EPD 市場的本質是動態的，受到不斷的技術進步和不斷變化的臨床需求的驅動。能夠適應這些變化並專注於以患者為中心的解決方案，同時應對監管和成本限制的公司可以鞏固其市場地位並推動業務顯著成長。

主要市場統計
基準年[2023] 17.2億美元
預測年份 [2024] 18.6億美元
預測年份 [2030] 29.8億美元
複合年成長率（%） 8.11%

市場動態：揭示快速發展的栓塞預防設備市場的關鍵市場洞察

供需的動態交互作用正在改變栓塞防護設備市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助企業了解消費行為及其對製造業的影響。

  • 市場促進因素
    • 心血管疾病和心臟病的增加
    • 政府不斷採取措施提高心臟健康意識並改善心臟病的診斷
    • 擴大手術中心，臨床參與栓塞預防裝置的研究
  • 市場限制因素
    • 發生栓塞防護裝置或系統的產品召回
  • 市場機會
    • 持續創新，提升栓塞防護裝置的功能、安全性和效率
    • 栓塞防護裝置核准的監管核准和支持
  • 市場問題
    • 栓塞防護裝置的性能問題與技術複雜性

波特的五力：駕馭栓塞預防設備市場的策略工具

波特的五力架構是了解栓塞預防設備市場競爭格局的關鍵工具。波特的五力框架描述了評估公司競爭和探索策略機會的清晰方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點，避免潛在的挑戰，確保更強大的市場地位。

PESTLE分析：了解栓塞預防設備市場的外部影響

外部宏觀環境因素在塑造栓塞防護設備市場的績效動態發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析：了解栓塞預防設備市場的競爭格局

對栓塞預防設備市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、細分和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣：栓塞預防設備市場供應商的績效評估

FPNV定位矩陣是評估栓塞防護器械市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議：繪製栓塞預防設備市場的成功之路

對於旨在加強在全球市場的影響力的公司來說，對栓塞預防設備市場進行策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

該報告對涵蓋關鍵焦點細分市場的市場進行了全面分析。

1.市場滲透率：對當前市場環境的詳細審查，主要企業的廣泛資料，評估他們在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有細分市場的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策。

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品和地區提供最佳投資機會？

3.塑造市場的關鍵技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 心血管疾病和心臟病的發生率增加
      • 政府努力提高人們對心臟健康的認知並改善心臟病的診斷
      • 擴大外科中心和臨床參與栓塞預防裝置的研究
    • 抑制因素
      • 發生栓塞防護裝置或系統的產品召回
    • 機會
      • 持續創新，提升栓塞防護裝置的功能、安全性和效率
      • 栓塞防護裝置核准的監管核准和支持
    • 任務
      • 栓塞防護裝置的性能問題與技術複雜性
  • 市場區隔分析
    • 設備類型：靈活性、有效性和微創性推動遠端過濾器的採用增加
    • 應用：對栓塞防護裝置的需求不斷成長，以管理大容量心血管干預和手術
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 經濟
    • 社會
    • 科技
    • 法律
    • 環境

第6章栓塞預防設備市場：依設備類型

  • 介紹
  • 遠端過濾器
  • 遠端阻塞設備
  • 近端阻塞設備

第7章栓塞預防設備市場：依應用分類

  • 介紹
  • 心血管外科
  • 神經血管手術

第8章栓塞預防設備市場：依最終使用者分類

  • 介紹
  • 門診手術中心
  • 醫院
  • 專科診所

第9章北美及南美栓塞預防設備市場

  • 介紹
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太地區栓塞預防設備市場

  • 介紹
  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲、中東和非洲的栓塞預防設備市場

  • 介紹
  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • Protembis GmbH 獲得 3,247 萬美元 B 輪資金籌措，加速 PROTEMBO 腦保護測試
    • AorticLab 創新 FLOWer 栓塞保護裝置獲得 CE 標誌核准
    • FDA核准F2 腦保護系統研究，EnCompass Technologies 達到里程碑
  • 戰略分析和建議

公司名單

  • Abbott Laboratories
  • AngioDynamics, Inc.
  • Balton Sp. z oo
  • Boston Scientific Corporation
  • Contego Medical, Inc.
  • Cook Group Incorporated
  • Cordis
  • Edwards Lifesciences Corporation
  • Emboline, Inc.
  • Filterlex Medical Ltd.
  • Inari Medical, Inc.
  • InspireMD Inc.
  • Invamed
  • Keystone Heart US, Inc. by Venus Medtech（Hangzhou）Inc.
  • Medtronic PLC
  • Meril Life Sciences Pvt. Ltd.
  • MicroPort Scientific Corporation
  • NIPRO CORPORATION
  • Penumbra, Inc.
  • Protembis GmbH
  • Silk Road Medical, Inc.
  • Stryker Corporation
  • Terumo Medical Corporation
  • Transverse Medical Inc.
  • WL Gore & Associates, Inc.
Product Code: MRR-8958E923A6B8

The Embolic Protection Devices Market was valued at USD 1.72 billion in 2023, expected to reach USD 1.86 billion in 2024, and is projected to grow at a CAGR of 8.11%, to USD 2.98 billion by 2030.

Embolic protection devices (EPDs) are critical in interventional cardiovascular procedures, designed to capture and remove debris that dislodges during procedures such as percutaneous coronary interventions (PCIs) and transcatheter aortic valve replacements (TAVRs). Their necessity stems from the need to prevent embolism, a major complication that can lead to strokes or myocardial infarctions. These devices find applications in various procedures, primarily focusing on the cardiovascular system, with end-use markets extending to hospitals, cardiac centers, and ambulatory surgical units. The growth of the EPD market is influenced by the increasing prevalence of cardiovascular diseases and a heightened preference for minimally invasive surgical techniques. Additionally, technological advancements in device design, such as improving patient safety and procedural efficacy, further drive the market. Notable opportunities lie in emerging markets where healthcare infrastructure is experiencing robust development, alongside an increasing number of skilled professionals and patient awareness regarding cardiovascular health. However, the market faces limitations such as high costs of devices, regulatory hurdles, and the need for skilled personnel to operate these advanced technologies efficiently. Challenges include intense competition and reimbursement issues which can impede market penetration. Innovation should focus on integrating artificial intelligence and machine learning to enhance device functionality and patient outcomes, as well as developing reusable and cost-effective devices to broaden accessibility. Exploring partnerships or collaborations with research institutions can also foster innovative solutions. The EPD market's nature is dynamic, driven by constant technological advancements and evolving clinical needs. Companies that can adapt to these changes and focus on patient-centered solutions, while addressing regulatory and cost constraints, stand to strengthen their market position and drive significant business growth.

KEY MARKET STATISTICS
Base Year [2023] USD 1.72 billion
Estimated Year [2024] USD 1.86 billion
Forecast Year [2030] USD 2.98 billion
CAGR (%) 8.11%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Embolic Protection Devices Market

The Embolic Protection Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing incidences of cardiovascular diseases and heart issues
    • Growing government initiatives to raise awareness for heart health and improve diagnosis of heart conditions
    • Expansion of surgical centers and involvement of clinics in research studies for embolic protection devices
  • Market Restraints
    • Incidences of product recall of embolic protection devices or systems
  • Market Opportunities
    • Ongoing innovations to improve functionality, safety, and efficiency of embolic protection devices
    • Regulatory approvals and support for authorization of embolic protection devices
  • Market Challenges
    • Performance issues and technical complexity of embolic protection devices

Porter's Five Forces: A Strategic Tool for Navigating the Embolic Protection Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Embolic Protection Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Embolic Protection Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Embolic Protection Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Embolic Protection Devices Market

A detailed market share analysis in the Embolic Protection Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Embolic Protection Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Embolic Protection Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Embolic Protection Devices Market

A strategic analysis of the Embolic Protection Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Embolic Protection Devices Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AngioDynamics, Inc., Balton Sp. z o. o., Boston Scientific Corporation, Contego Medical, Inc., Cook Group Incorporated, Cordis, Edwards Lifesciences Corporation, Emboline, Inc., Filterlex Medical Ltd., Inari Medical, Inc., InspireMD Inc., Invamed, Keystone Heart US, Inc. by Venus Medtech (Hangzhou) Inc., Medtronic PLC, Meril Life Sciences Pvt. Ltd., MicroPort Scientific Corporation, NIPRO CORPORATION, Penumbra, Inc., Protembis GmbH, Silk Road Medical, Inc., Stryker Corporation, Terumo Medical Corporation, Transverse Medical Inc., and W. L. Gore & Associates, Inc..

Market Segmentation & Coverage

This research report categorizes the Embolic Protection Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Device Type, market is studied across Distal Filters, Distal Occlusion Devices, and Proximal Occlusion Devices.
  • Based on Application, market is studied across Cardiovascular Procedures and Neurovascular Procedures.
  • Based on End-User, market is studied across Ambulatory Surgical Centers, Hospitals, and Specialty Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing incidences of cardiovascular diseases and heart issues
      • 5.1.1.2. Growing government initiatives to raise awareness for heart health and improve diagnosis of heart conditions
      • 5.1.1.3. Expansion of surgical centers and involvement of clinics in research studies for embolic protection devices
    • 5.1.2. Restraints
      • 5.1.2.1. Incidences of product recall of embolic protection devices or systems
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing innovations to improve functionality, safety, and efficiency of embolic protection devices
      • 5.1.3.2. Regulatory approvals and support for authorization of embolic protection devices
    • 5.1.4. Challenges
      • 5.1.4.1. Performance issues and technical complexity of embolic protection devices
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Device Type: Emerging adoption of distal filters owing to their flexibility, effectiveness, and minimally invasive nature
    • 5.2.2. Application: Expanding need for embolic protection devices to manage the large volume of cardiovascular interventions and surgeries
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Embolic Protection Devices Market, by Device Type

  • 6.1. Introduction
  • 6.2. Distal Filters
  • 6.3. Distal Occlusion Devices
  • 6.4. Proximal Occlusion Devices

7. Embolic Protection Devices Market, by Application

  • 7.1. Introduction
  • 7.2. Cardiovascular Procedures
  • 7.3. Neurovascular Procedures

8. Embolic Protection Devices Market, by End-User

  • 8.1. Introduction
  • 8.2. Ambulatory Surgical Centers
  • 8.3. Hospitals
  • 8.4. Specialty Clinics

9. Americas Embolic Protection Devices Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Embolic Protection Devices Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Embolic Protection Devices Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Protembis GmbH Secures USD 32.47 Million in Series B Funding to Accelerate the PROTEMBO Cerebral Protection Trial
    • 12.3.2. AorticLab Achieves CE Mark Approval for Innovative FLOWer Embolic Protection Device
    • 12.3.3. EnCompass Technologies Achieves Milestone with FDA Approval for F2 Cerebral Protection System Study
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. AngioDynamics, Inc.
  • 3. Balton Sp. z o. o.
  • 4. Boston Scientific Corporation
  • 5. Contego Medical, Inc.
  • 6. Cook Group Incorporated
  • 7. Cordis
  • 8. Edwards Lifesciences Corporation
  • 9. Emboline, Inc.
  • 10. Filterlex Medical Ltd.
  • 11. Inari Medical, Inc.
  • 12. InspireMD Inc.
  • 13. Invamed
  • 14. Keystone Heart US, Inc. by Venus Medtech (Hangzhou) Inc.
  • 15. Medtronic PLC
  • 16. Meril Life Sciences Pvt. Ltd.
  • 17. MicroPort Scientific Corporation
  • 18. NIPRO CORPORATION
  • 19. Penumbra, Inc.
  • 20. Protembis GmbH
  • 21. Silk Road Medical, Inc.
  • 22. Stryker Corporation
  • 23. Terumo Medical Corporation
  • 24. Transverse Medical Inc.
  • 25. W. L. Gore & Associates, Inc.

LIST OF FIGURES

  • FIGURE 1. EMBOLIC PROTECTION DEVICES MARKET RESEARCH PROCESS
  • FIGURE 2. EMBOLIC PROTECTION DEVICES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DEVICE TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DEVICE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS EMBOLIC PROTECTION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS EMBOLIC PROTECTION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES EMBOLIC PROTECTION DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES EMBOLIC PROTECTION DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC EMBOLIC PROTECTION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC EMBOLIC PROTECTION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EMBOLIC PROTECTION DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. EMBOLIC PROTECTION DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. EMBOLIC PROTECTION DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. EMBOLIC PROTECTION DEVICES MARKET DYNAMICS
  • TABLE 7. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DISTAL FILTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DISTAL OCCLUSION DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY PROXIMAL OCCLUSION DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY CARDIOVASCULAR PROCEDURES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY NEUROVASCULAR PROCEDURES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS EMBOLIC PROTECTION DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 31. MEXICO EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES EMBOLIC PROTECTION DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC EMBOLIC PROTECTION DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 42. AUSTRALIA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 45. CHINA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 48. INDIA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 51. INDONESIA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. JAPAN EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 57. MALAYSIA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 60. PHILIPPINES EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. SINGAPORE EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 66. SOUTH KOREA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 69. TAIWAN EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 72. THAILAND EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 75. VIETNAM EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 82. DENMARK EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. EGYPT EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. FINLAND EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. FRANCE EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 94. GERMANY EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. ISRAEL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. ITALY EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 103. NETHERLANDS EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 106. NIGERIA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 109. NORWAY EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 112. POLAND EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 115. QATAR EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 118. RUSSIA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 121. SAUDI ARABIA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH AFRICA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 127. SPAIN EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 130. SWEDEN EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 133. SWITZERLAND EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 136. TURKEY EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED ARAB EMIRATES EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED KINGDOM EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 145. EMBOLIC PROTECTION DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 146. EMBOLIC PROTECTION DEVICES MARKET, FPNV POSITIONING MATRIX, 2023